Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Smith & Nephew Snats (SNN)
:SNN
RESEARCH TOOLSreports
Holding SNN?
Track your performance easily
Earnings Data
Report Date
Feb 25, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.92Last Year’s EPS
1.31Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 07, 2019
|% Change Since: -11.33%
|Next Earnings Date:Jul 26, 2018
Earnings Call Sentiment|Positive
The earnings call reflects a positive overall sentiment, driven by strong revenue growth, margin achievement, and significant advancements in Sports Medicine, ENT, and Advanced Wound Management. However, challenges in U.S. Reconstruction and the impact of China VBP present notable headwinds.Company Guidance
During the Smith & Nephew Q4 and Full Year 2023 earnings call, CEO Deepak Nath and CFO Anne-Francoise Nesmes provided comprehensive guidance, highlighting several key metrics. The company reported an underlying revenue growth of 7.2%, totaling $5.5 billion, and a trading profit increase of 7.6% to $970 million, achieving a trading margin of 17.5%. The business units, including Sports Medicine and ENT, saw double-digit growth, and Orthopedics showed progress with a 12-Point Plan. Despite macroeconomic headwinds, the company maintained a 65% trading cash conversion rate, with adjusted earnings per share rising by 1.3% to $0.828. For 2024, Smith & Nephew anticipates 5% to 6% underlying revenue growth and margin expansion to at least 18%, while addressing challenges like the China VBP impact on Sports Medicine. The strategic focus on innovation and operational improvements is expected to drive continued growth and margin enhancement into 2025, targeting a trading margin of at least 20%.Strong Revenue Growth
Revenue reached $5.5 billion, a 7.2% growth on an underlying basis and 6.4% on a reported basis despite an 80 basis points headwind from foreign exchange.
Margin Target Achieved
Achieved a trading margin of 17.5% for the year, aligning with guidance despite facing macroeconomic headwinds.
Sports Medicine and ENT Performance
Sports Medicine and ENT achieved double-digit growth, contributing significantly to the company's performance.
Advanced Wound Management Growth
Advanced Wound Management delivered 6.4% growth for the year, with a significant increase in Advanced Wound Devices revenue.
CORI Adoption and Utilization
CORI placements reached a new high, with utilization also increasing, indicating strong adoption in the market.
---
SNN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SNN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Aug 01, 2024 | $28.52 | $30.48 | +6.87% |
| Feb 27, 2024 | $27.77 | $27.21 | -2.02% |
| Aug 03, 2023 | $28.18 | $27.39 | -2.80% |
| Feb 21, 2023 | $26.36 | $27.82 | +5.54% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Smith & Nephew Snats (SNN) report earnings?
Smith & Nephew Snats (SNN) is schdueled to report earning on Feb 25, 2025, TBA Not Confirmed.
What is Smith & Nephew Snats (SNN) earnings time?
Smith & Nephew Snats (SNN) earnings time is at Feb 25, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SNN EPS forecast?
SNN EPS forecast for the fiscal quarter 2024 (Q4) is 0.92.
---